Oral Mucormycosis: Post Complication of COVID Era
Published: 2021-08-05
Page: 155-163
Issue: 2021 - Volume 4 [Issue 2]
Ankita Garg *
Department of Periodontology, Kanti Devi Dental College and Hospital, Mathura, Uttar Pradesh, India.
Satendra Sharma
Department of Periodontology, Kanti Devi Dental College and Hospital, Mathura, Uttar Pradesh, India.
Shailendra Singh Chauhan
Department of Periodontology, Kanti Devi Dental College and Hospital, Mathura, Uttar Pradesh, India.
Aditya Sinha
Department of Periodontology, Kanti Devi Dental College and Hospital, Mathura, Uttar Pradesh, India.
Mohan Rawat
Department of Periodontology, Kanti Devi Dental College and Hospital, Mathura, Uttar Pradesh, India.
. Deepika
Department of Periodontology, Kanti Devi Dental College and Hospital, Mathura, Uttar Pradesh, India.
*Author to whom correspondence should be addressed.
Abstract
Mucormycosis is an invasive and potentially lethal fungal infection and a rare terminal complication of uncontrolled diabetes and other chronic debilitating diseases. The incidence of disease has increased considerably due to widespread use of antibiotics, steroids and longterm use of humidifiers in corona positive patients. Despite surgical and antifungal treatments the mortality rate is higher than 50% and even higher in immunocompromised patients. The role of dentist is of immense importance because mucormycosis primarily occurs around rhinomaxillary or rhino cerebral areas involving facial tissues, palate, alveolar bone and mandibular bone. The present article briefly reviews pathogenesis, signs and symptoms, risks and complications, diagnosis and the management of the mucormycosis.
Keywords: Oral Mucormycosis, Covid-19, Diabetes, Antifungal therapy